Novartis is committed to transforming immunology by investing in breakthrough science to address the highest unmet needs. Leveraging diverse platforms like cell and gene therapy, small molecule degraders, multispecific biotherapeutics, Novartis develops therapies that target the root causes of immune diseases. As a market leader in deal-making, Novartis partners with innovators to bring game-changing solutions to patients.